Chemoinformaics analysis of Pyrrole-2-carboxaldehyde
Molecular Weight | 95.101 | nRot | 1 |
Heavy Atom Molecular Weight | 90.061 | nRig | 6 |
Exact Molecular Weight | 95.0371 | nRing | 1 |
Solubility: LogS | -0.903 | nHRing | 1 |
Solubility: LogP | 0.921 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
nHA | 1 | APOL | 13.586 |
nHD | 1 | BPOL | 6.45403 |
QED | 0.515 |
Synth | 3.023 |
Natural Product Likeliness | 0.175 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.012 |
CACO-2 | -4.284 |
MDCK | 0.0000157 |
BBB | 0.996 |
PPB | 0.276475 |
VDSS | 1.183 |
FU | 0.79652 |
CYP1A2-inh | 0.564 |
CYP1A2-sub | 0.416 |
CYP2c19-inh | 0.06 |
CYP2c19-sub | 0.13 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.858 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.477 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.157 |
CL | 8.065 |
T12 | 0.876 |
hERG | 0.024 |
Ames | 0.088 |
ROA | 0.845 |
SkinSen | 0.405 |
Carcinogencity | 0.24 |
EI | 0.994 |
Respiratory | 0.982 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.880075 |